MarketWatch
Search documents
2025 was one hell of a year for consumers. What can we learn from it?
MarketWatch· 2025-12-15 10:15
Core Viewpoint - The year began with significant market volatility due to President Donald Trump's inauguration and the introduction of tariffs, which led to a rapid shift in investor behavior from selling to buying [1] Group 1: Market Reactions - The implementation of tariffs caused shockwaves in the stock market, prompting investors to rapidly change their positions [1] - Initial reactions included widespread selling, followed by a rebound as investors shifted to buying [1] Group 2: Supply Chain Impact - Supply-chain issues have resulted in increased costs across various sectors, affecting prices of essential goods such as groceries, clothing, and cars [1]
The last major Wall Street bank to set its 2026 target forecasts double-digit gains for the S&P 500
MarketWatch· 2025-12-15 10:00
Core Insights - High valuations in the market are seen as a challenge but are not considered an insurmountable barrier for future growth and investment opportunities [1] Market Valuation - Current market valuations are elevated, which may deter some investors from entering the market [1] - Despite high valuations, historical data suggests that markets can continue to perform well even in such conditions [1] Investment Opportunities - Companies with strong fundamentals and growth potential may still attract investment despite high market valuations [1] - The focus should be on identifying sectors and companies that can deliver robust earnings growth [1] Economic Indicators - Economic indicators suggest a mixed outlook, with some sectors showing resilience while others may face headwinds [1] - Monitoring economic trends will be crucial for assessing future market performance [1]
Sanofi stock slumps after two setbacks on multiple-sclerosis drug
MarketWatch· 2025-12-15 09:43
Core Viewpoint - Shares of Sanofi experienced a decline following the announcement that the U.S. regulatory review of its multiple-sclerosis drug will not be completed by the end of the year [1] Group 1: Company Updates - Sanofi's multiple-sclerosis drug is facing delays in the U.S. regulatory review process, which is now expected to extend beyond the end of the year [1] - The company also indicated that a trial for a different form of treatment is ongoing, but specific details were not provided [1]
Roomba maker iRobot files for bankruptcy, will go private
MarketWatch· 2025-12-15 01:21
Core Insights - iRobot, the maker of Roomba, has filed for Chapter 11 bankruptcy and will transfer its business to two Chinese companies, marking a significant decline in its market position [1] Company Summary - The decision to file for bankruptcy comes after a prolonged period of financial struggles for iRobot, indicating a major shift in its operational strategy [1] - The acquisition by Chinese firms suggests a move towards privatization, which may alter the company's future direction and management [1] Industry Context - The bankruptcy filing reflects broader challenges within the robotics and consumer electronics sectors, where companies face increasing competition and market pressures [1] - The involvement of foreign companies in acquiring American tech firms highlights ongoing trends in global investment and market consolidation [1]
U.S. stock futures little changed ahead of year's last full week of trading
MarketWatch· 2025-12-14 23:18
Core Viewpoint - Stocks experienced a decline on Friday, primarily driven by a significant drop in the tech sector, as investors are engaging in a "rotation trade" away from AI stocks [1] Group 1 - The tech sector led the decline in stock prices on Friday [1] - Investors are shifting their focus away from AI stocks, indicating a potential change in market sentiment [1]
Hassett says Trump would have ‘no weight' on Fed's decision-making if he's chair
MarketWatch· 2025-12-14 21:54
Core Viewpoint - Kevin Hassett, President Donald Trump's top economic adviser, has dismissed concerns regarding his potential role as the next Federal Reserve chair, asserting that he would not merely push Trump's agenda [1] Group 1 - Hassett's potential appointment as Fed chair raises questions about independence from political influence [1] - He emphasizes that his focus would be on economic stability rather than political objectives [1] - The discussion reflects broader concerns about the Federal Reserve's autonomy in the face of political pressures [1]
Stocks risk a stir-up in last trading push of the year. Where to put your money.
MarketWatch· 2025-12-14 17:00
Core Insights - The delayed November jobs report and key inflation readings are contributing factors to potential market volatility [1] Group 1 - The November jobs report is anticipated to provide insights into employment trends, which could influence market sentiment [1] - Key inflation readings are expected to impact monetary policy decisions, further affecting market dynamics [1] - Other factors beyond the jobs report and inflation data may also contribute to market turmoil [1]
Kevin Warsh's odds of becoming Fed chair leap higher as Dimon signals support
MarketWatch· 2025-12-13 21:08
Core Viewpoint - President Trump is considering either Warsh or Kevin Hassett as potential successors to current Fed chair Jerome Powell [1] Group 1 - The decision on the new Fed chair is significant for monetary policy direction [1] - Warsh and Hassett are both prominent figures with different backgrounds and perspectives on economic issues [1]
Walmart was too late for a Nasdaq-100 spot — but these 6 stocks made the cut
MarketWatch· 2025-12-13 16:04
Group 1 - Six companies will be added to the Nasdaq-100 index later this month [1] - Walmart will not be included in the Nasdaq-100 due to its late switch from the New York Stock Exchange [1]
AI is crushing these once-reliable tech stocks. Are investors missing the point?
MarketWatch· 2025-12-13 14:00
Core Insights - FactSet and Gartner are identified as some of the worst performers in the S&P 500 this year, indicating challenges in their stock performance [1] - Despite their current struggles, analysts on Wall Street perceive these companies as having resilient and adaptable business models, particularly in the context of artificial intelligence (AI) [1] Company Performance - FactSet and Gartner have faced significant declines in their stock prices, contributing to their status as underperformers in the S&P 500 [1] - The market's reaction to these companies suggests a disconnect between their long-term business potential and short-term stock performance [1] Industry Adaptation - Analysts believe that both companies possess the ability to adapt to the evolving landscape shaped by AI technologies [1] - The resilience of their business models is seen as a positive indicator for future performance, despite current market challenges [1]